Results 61 to 70 of about 6,452 (220)
ABSTRACT Hepatocellular carcinoma (HCC) is the most common subtype of primary liver cancer, with significant variability in patient outcomes even within the same stage according to the Barcelona Clinic Liver Cancer staging system. Accurately predicting patient prognosis and potential treatment response prior to therapy initiation is crucial for ...
Feng Che +5 more
wiley +1 more source
Magnetic mg‐Fe3O4‐APTES nanoparticle‐doped p(HEMA)‐phenylboronic acid cryogel membranes are developed for the efficient removal of dopamine from pharmaceutical wastewater. Utilizing boronate affinity interactions, the system demonstrates a high adsorption capacity of 1969.1 mg/g and eliminates 81.3% of the target molecule within 15 minutes.
Cansu İlke Kuru‐Sumer +2 more
wiley +1 more source
There are a few things you should know before you start looking for properties for sale in Taree. You can read about some basic tips and ideas on the Soho Property Pte. Ltd. website. Soho allows you to search the most recent Taree real estate listings and pick your favourite houses for sale.
openaire +1 more source
Aim: To meta-analyze the utility of transarterial radioembolization (TARE) in patients with liver metastatic breast cancer (BC), based on the objective response rate (ORR) and disease control rate (DCR).
Natale Quartuccio +6 more
doaj +1 more source
Transarterial Radioembolization (TARE) Agents beyond 90Y-Microspheres
Liver malignancies, either primary tumours (mainly hepatocellular carcinoma and cholangiocarcinoma) or secondary hepatic metastases, are a major cause of death, with an increasing incidence. Among them, hepatocellular carcinoma (HCC) presents with a dark prognosis because of underlying liver diseases and an often late diagnosis.
Bouvry, C. +6 more
openaire +4 more sources
Systemic therapy (ST) and transarterial radioembolization (TARE) are widely used treatments for advanced-stage hepatocellular carcinoma (HCC). This study quantified the significant variability in treatment costs for unresectable HCC from payer and ...
Abimbola O. Williams +3 more
doaj +1 more source
Background: The present study aims to investigate the superiority of TARE-Y90 in the treatment of liver metastases from colorectal cancer in comparison to DEBIRI and perform a parallel resource consumption study to demonstrate a possible favorable cost ...
Juan José Ciampi-Dopazo +9 more
doaj +1 more source
The aim of this study was to evaluate outcomes of transarterial radioembolization (TARE) for hepatocellular carcinoma (HCC) in patients previously treated with transarterial embolization (TAE).
Ken Zhao +12 more
doaj +1 more source

